Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Genfit SA ( (GNFT) ).
On June 17, 2025, GENFIT announced the results of its Combined Shareholders Meeting, where all board-recommended resolutions were approved except for resolution n°28. The meeting, which had a quorum of 27.21%, reflects shareholder support for the company’s strategic direction. This approval is significant for GENFIT as it continues to advance its R&D initiatives in liver disease treatment and diagnostics, potentially impacting its market position and stakeholder interests.
The most recent analyst rating on (GNFT) stock is a Buy with a $13.00 price target. To see the full list of analyst forecasts on Genfit SA stock, see the GNFT Stock Forecast page.
Spark’s Take on GNFT Stock
According to Spark, TipRanks’ AI Analyst, GNFT is a Neutral.
Genfit SA demonstrates strong financial recovery with significant revenue growth and cash flow improvement, but faces challenges with operating margins and valuation. Technical indicators provide a mixed outlook, with potential for upward movement despite current valuation concerns.
To see Spark’s full report on GNFT stock, click here.
More about Genfit SA
GENFIT is a biopharmaceutical company focused on developing treatments for rare and life-threatening liver diseases. With a strong history in liver disease research, GENFIT has a diverse R&D portfolio, including programs for Acute-on-Chronic Liver Failure (ACLF) and other serious conditions like cholangiocarcinoma and urea cycle disorder. The company is also involved in diagnostics, with products targeting metabolic dysfunction-associated steatohepatitis and blood ammonia levels. GENFIT is headquartered in Lille, France, and operates in Paris, Zurich, and Cambridge, MA.
Average Trading Volume: 12,239
Technical Sentiment Signal: Buy
Current Market Cap: $209M
For detailed information about GNFT stock, go to TipRanks’ Stock Analysis page.